InvestSMART

Genera Biosystems Limited (ASX: GBI) - Announcements

DELISTED - Current share price for GBI : $0.160

ASX company news and announcements for Genera Biosystems Limited (GBI) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Genera Biosystems Limited (GBI) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Genera Biosystems Limited (GBI), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Genera Biosystems Limited (GBI)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
- Business Update and March 2017 Appendix 4C 1 May 2017 8:55AM $0.170 $0.160 fallen by 5.88%
- Change of Director's Interest Notice 26 Apr 2017 8:42AM $0.180 $0.160 fallen by 11.11%
- Change of Director's Interest Notice 20 Apr 2017 9:20AM $0.180 $0.160 fallen by 11.11%
- Change of Director's Interest Notice 13 Apr 2017 5:49PM $0.180 $0.160 fallen by 11.11%
- Change of Director's Interest Notice 7 Apr 2017 2:53PM $0.200 $0.160 fallen by 20%
- Outstanding Series B note holder receipt 3 Apr 2017 3:45PM $0.190 $0.160 fallen by 15.79%
- Variation of Existing Series B Convertible Notes 3 Apr 2017 9:26AM $0.190 $0.160 fallen by 15.79%
- Change of Director's Interest Notice 29 Mar 2017 11:30AM $0.180 $0.160 fallen by 11.11%
- Change in substantial holding 24 Mar 2017 3:24PM $0.180 $0.160 fallen by 11.11%
- Change of Director's Interest Notice 24 Mar 2017 9:50AM $0.180 $0.160 fallen by 11.11%
- Change of Director's Interest Notice 17 Mar 2017 8:55AM $0.200 $0.160 fallen by 20%
- Change of Director's Interest Notice 8 Mar 2017 3:03PM $0.225 $0.160 fallen by 28.89%
- Appendix 4D and Half Year Financial Report 28 Feb 2017 4:37PM $0.190 $0.160 fallen by 15.79%
- Business Update and December 2016 Appendix 4C 31 Jan 2017 3:20PM $0.240 $0.160 fallen by 33.33%
- Agreement to Variation of Existing Mezzanine Debt Facility 30 Dec 2016 9:07AM $0.270 $0.160 fallen by 40.74%
- Agreement to Variation of Existing Series B Notes 29 Dec 2016 9:15AM $0.250 $0.160 fallen by 36%
- Change of Director's Interest Notice 23 Dec 2016 4:19PM $0.250 $0.160 fallen by 36%
- Appendix 3B 23 Dec 2016 4:16PM $0.250 $0.160 fallen by 36%
- Proposed Amendments to Existing Series B Convertible Notes 13 Dec 2016 12:19AM $0.240 $0.160 fallen by 33.33%
- Results of Annual General Meeting 24 Nov 2016 1:44PM $0.300 $0.160 fallen by 46.67%
- 2016 CEO AGM Presentation 24 Nov 2016 11:18AM $0.300 $0.160 fallen by 46.67%
- Genera Receives R&D Tax Rebate 21 Nov 2016 9:59AM $0.295 $0.160 fallen by 45.76%
- Genera anticipates to receive $752k R&D rebate 15 Nov 2016 10:45AM $0.275 $0.160 fallen by 41.82%
- Appendix 3B 11 Nov 2016 2:54PM $0.230 $0.160 fallen by 30.43%
- Genera Lodges Application for PapType Medicare Benefits 11 Nov 2016 2:20PM $0.210 $0.160 fallen by 23.81%

101 - 125 of 275 results

Page 5 of 11

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.